"Despite some challenges, 2023 was a year of great achievements and exciting opportunities. I am grateful for the dedication of the
The Annual Report for 2023 is attached to this notice and available on the Company's website under the Investor Relations section. The auditor's report, which is incorporated in the annual report, includes a statutory emphasis of matter relating to the further financing of the Company.
For further information, please contact:
Jørgen Mann, Interim CEO
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.
The Company is headquartered in
Further information is available at www.observemedical.com.
https://news.cision.com/observe-medical-asa/r/observe-medical-annual-report-for-2023,c3968940
https://mb.cision.com/Main/19175/3968940/2771755.pdf
https://mb.cision.com/Main/19175/3968940/2771756.zip
(c) 2024 Cision. All rights reserved., source